Psychiatric News February 18, 2005
Volume 40 Number 4
© 2005 American Psychiatric Association
p. 26
Preliminary Program: TUESDAY MAY24
7 a.m.-8:30 a.m.
Industry-Supported Breakfast Symposia IS31. Agitation and Psychosis in
Alzheimer's Disease and Parkinson's Disease (Part 2) Supported by
AstraZeneca Pharmaceuticals
A. Efficacy and Tolerability of Atypical Antipsychotics in Agitation and
Psychosis: Clinical Applications Jeanne Jackson-Siegel, M.D.
B. Treatment of Psychosis in Parkinson's Disease Jeffrey L. Cummings,
M.D.
IS32. Managing the Spectrum of Bipolar Disorder: Minimizing the Burden
of Disease (Part 2) Supported by Bristol-Myers Squibb Company
A. The Impact of Safety and Tolerability on Patient Satisfaction With
Therapy Paul E. Keck Jr., M.D.
B. Impact of Bipolar Maintenance Therapy on Patient Outcomes Lori L.
Altshuler, M.D.
IS33. Advances in the Treatment of Mood and Anxiety Disorders in Women
(Part 2) Supported by Wyeth Pharmaceuticals
A. Perinatal Consequences of Mood and Anxiety Disorders Kimberly A.
Yonkers, M.D.
B. Menopausal Transition: Impact on Mood, Sleep, and Quality of Life
Claudio N. Soares, M.D.
C. Managing Bipolar Disorder in Women Lesley M. Arnold, M.D.
7:30 a.m.-6 p.m.
Registration/Course Enrollment Open
8 a.m.-Noon
CME Courses 59-65
9 a.m.-10:30 a.m.
Clinical Case Conference 2. Elisabeth J.S. Kunkel, M.D., Angel
Angelov, M.D., Larissa Chism, M.D., Dimitri D. Markov, M.D., on
Consultation-Liaison Casebook Challenge: Strategies and Limitations in
Establishing Competency (for APA members only)
Discussion Groups
9. Pedro Ruiz, M.D., on The Role of Culture in Psychiatric
Practice (for residents only)
10. K. Ranga R. Krishnan, M.D., on Psychiatric Diagnosis:
Approaches in the Post-Genomic Era Collaborative Session With the National
Institute of Mental Health
11. Katherine L. Wisner, M.D., on Postpartum Mood Disorders
12. Ronald W. Pies, M.D., on The Great Bipolar Depression
Controversy: A Pragmatic Approach (Meet the Authors)
Lectures
L10. From Genes to Therapeutics: New Approaches to Schizophrenia
Robert Freedman, M.D., Distinguished Psychiatrist Lecture Series;
Collaborative Session With the National Institute of Mental Health
L11. Leadership Through Example: Mentorship and Networking
(Presented by Russell Lim, M.D.) K. Patrick Okura, Ph.D., APA's Kun-Po Soo
Award Lecture
Master Educator Clinical Consultations
5. Harold Kudler, M.D., on PTSD and Deployment Mental Health
(for APA members only)
6. John D. Wynn, M.D., on Psychosomatics and the Medically Complex
Patient: Sorting Out Axis I, II, and III (for APA members only)
Round-Table Discussion on Safety and Efficacy of SSRI Antidepressants in
Children and Adolescents: What Do We Know and When Did We Know It?
Moderator: Richard E. D'Alli, M.D.
Component Workshops
CW18. "Y" Psychotherapy: An Integrated, Evidence-Based
Psychotherapy Competency Model APA Committee on Psychotherapy by
Psychiatrists; Co-Chairpersons: Eric M. Plakun, M.D., Lisa A. Mellman,
M.D.
CW19. Patient Safety: Evaluating an Adverse Event and Implementing
Safeguards APA Committee on Patient Safety; Chairperson: Paul R.
McHugh, M.D.
CW20. Closing Practice: What Every Psychiatrist's Office and His/Her
Family Should Know APA Corresponding Committee on Physician Health,
Illness, and Impairment; Chairperson: John A. Fromson, M.D.
CW21. Novel Careers in Psychiatry: Women Who Have Made Their Own Way
APA Committee on Women; Co-Chairpersons: Melva I. Green, M.D., Carrie L.
Ernst, M.D.
CW22. Reversing the Criminalization of the Seriously Mentally Ill
APA Corresponding Committee on Jails and Prisons; Chairperson: Henry C.
Weinstein, M.D.
CW23. Disaster Psychiatry: Challenges and Novel Strategies for Residency
Training APA Committee on Psychiatric Dimensions of Disasters;
Co-Chairpersons: Diane E. McLean, M.D., Anthony T. Ng, M.D.
CW24. Ethnicity, Culture, and Response to Disaster Among Hispanics
APA Committee of Hispanic Psychiatrists; Chairperson: Eugenio M. Rothe,
M.D.
CW25. Suicide Among Ethnic Elders APA Committee on Ethnic
Minority Elderly; Co-Chairpersons: Iqbal Ahmed, M.D., Warachal E. Faison,
M.D.
CW26. Using the HIV Dementia Scale in the Clinical Setting APA
Committee on AIDS; Chairperson: Karl Goodkin, M.D.
Issue Workshops
IW27. Are There Limits to Boundary Limits? Chairperson: Malkah
T. Notman, M.D.
IW28. Children of Psychiatrists: Listen and Learn
Co-Chairpersons: Leah J. Dickstein, M.D., Michelle B. Riba, M.D.
IW29. ABPN and APA Perspectives on Maintenance of Certification
Chairperson: Stephen C. Scheiber, M.D.
IW30. How to Launch a Successful Private Practice (Part 1)
Co-Chairpersons: William E. Callahan Jr., M.D., Keith W. Young,
M.D.
IW31. Pain Management of the Chemically Dependent Patient
Chairperson: Jeffrey A. Berman, M.D.
IW32. Strategies for Success for Early Career Academic Psychiatrists
(Part 1): Writing for Publication Chairperson: Laura W. Roberts, M.D.;
Collaborative Session With the National Institute of Mental Health
IW33. Decisional Capacity in the Consultation-Liaison Setting:
Controversies and Difficulties Chairperson: Ramaswamy Viswanathan,
M.D.
IW34. Psychiatric Hospice on an ACT Team: When Mental Illness Is
Terminal Co-Chairpersons: Curtis N. Adams Jr., M.D.. Ann L. Hackman,
M.D.
IW35. Detection of Malingering in Disability Evaluations
Chairperson: Roger Z. Samuel, M.D.
IW36. Teaching Psychosomatic Medicine for Primary Care Physicians: What,
How, and Where? Chairperson: Hoyle Leigh, M.D.
IW37. Shakespeare, Psychiatry, and Psychopathology Chairperson:
Steven E. Pflanz, M.D.
IW38. Uncovering Medical Causes of Functional Decline in the
Developmentally Disabled Chairperson: Stephen M. Soltys, M.D.
IW39. Drug Companies in Training Clinics: Economic Necessity Versus
Undue Influence Co-Chairpersons: Edward A. Volkman, M.D., Ruth M.
Lamdan, M.D.
IW40. Driving Miss Daisy Co-Chairpersons: Theron C. Bowers Jr.,
M.D., Sheila M. Loboprabhu, M.D.
IW41. Psychiatrists Intervening Upstream: Good Practices for Preventing
Violence in Children, Youth, and Families Chairperson: Guiseppe
Raviola, M.D.; Collaborative Session With the National Institute of Mental
Health
IW42. Cultural Competence in the Clinical Encounter: Irma Bland and
Evelyn Lee Chairperson: Francis G. Lu, M.D.
IW43. A New Model for the Treatment of Relational Disorders
Co-Chairpersons: Glenn N. Siegel, M.D., Mary Pittman, M.S.
9 a.m.-11a.m.
Research Advances in Medicine
Exploring New Frontiers and Clinical Applications Chairperson:
Charles B. Nemeroff, M.D.; Co-Chairperson: Marian I. Butterfield,
M.D.
9 a.m.-Noon
Continuous Clinical Case Conference 1. Eva M. Szigethy, M.D.,
John Campo, M.D., David DeMaso, M.D., Eyal Shemesh, M.D., on Control What
You Can: Successful Treatment of Teenagers in Chronic Pain (Part 2) (for
APA members only)
Media Workshops
MW4. "Jim in Bold": Gay, Lesbian, and Transgender Teens on
Film American Academy of Child and Adolescent Psychiatry's Sexual
Orientation Committee; Co-Chairpersons: Richard R. Pleak, M.D., Sara E.
Herbert, M.D.
MW5. Long-Term Management of Schizophrenia in the Film "Out of the
Shadow" Co-Chairpersons: Stephen M. Goldfinger, M.D., Susan E.
Smiley, B.S.
MW6. Intergenerational Family Abuse: A Documentary Film
Chairperson: Barry Herman, M.D.
9 a.m.-12:30 p.m.
Advances in Psychosomatic Medicine Psychiatric Care of the Medically
Ill American Psychiatric Publishing Inc. Editorial Board; Chairperson:
James L. Levenson, M.D.
9 a.m.-4 p.m.
CME Courses 66-72
10 a.m.-6 p.m.
Exhibits Open (last day)
APA Member Center Open (last day)
Publishers' Bookfair Open (last day)
11 a.m.-12:30 p.m.
Discussion Groups
13. Joel Yager, M.D., on Career Building in Academic and
Nonacademic Psychiatry (for residents only)
14. Tana A. Grady-Weliky, M.D., on Effective Teaching: What
Psychiatry Residents Need to Know
15. John A. Chiles, M.D., on Assessment and Treatment of Suicidal
Patients (Meet the Authors)
Lectures
L12. Psychiatry in the Genomic Era Thomas R. Insel, M.D., APA's
Judd Marmor Award Lecture; Collaborative Session With the National Institute
of Mental Health
L13. To Be Announced APA's Patient Advocacy Award
Lecture
Master Educator Clinical Consultations
7. Josepha A. Cheong, M.D., on Geriatric Psychiatry (for APA
members only)
8. Silvia W. Olarte, M.D. (for APA members only)
Medical Update 2. Sara Berga, M.D., on Stress-Induced
Anovulation: Mind Over Matter
Research Consultation 2. Helen S. Mayberg, M.D., on
Functional Neuroimaging Strategies in Affective Disorders Research
Collaborative Session With the National Institute of Mental
Health
Scientific and Clinical Report Sessions
Session 10. Epidemiology and Other Issues in Psychiatry
29. Parental Separation at Birth and Schizophrenia and Depression Pirjo
H. Maki, M.D.
30. Parental Separation at Birth and Substance-Use Disorder Juha M.
Veijola, Ph.D.
31. Pica Syndrome: Review and Relevance Jambur V. Ananth, M.D.
Session 11. Somatic Therapies
32. The Impact of Electroconvulsive Therapy on Quality of Life and Function
W. Vaughn McCall, M.S.
33. Seizures Targeted to Circuitry: New Forms of Convulsive Therapy
Sarah H. Lisanby, M.D.; Collaborative Session With the National Institute
of Mental Health
34. Ethical and Legal Implications of Psychiatric Evaluation of Pediatric
Gastric Bypass Gagan Dhaliwal, M.D.
Session 12. Cognitive Disorders
35. Is Depression a Risk Factor for Cognitive Impairment? A Meta-Analysis
of 20 Cohort Studies Alex J Mitchell, M.D.
36. Treatment of Agitation and Psychosis in Elderly Patients With Dementia
Pierre N. Tariot, M.D.
37. Prevalence of Dementia in a Southern-European Population in Two
Different Time Periods Pedro Saz, M.D.
Session 13. Psychosomatic Medicine
38. Somatization Increases Medical Care Utilization and Costs Arthur J.
Barsky, M.D.
39. The Integrated Management of Medically Unexplained Symptoms Donald
Bakal, Ph.D.
40. Medical and Psychiatric Comorbidities of a Substance-Abusing
Public-Assistance Population Bruce J. Schwartz, M.D.
Session 14. Biological Psychiatry and Neuroscience
41. Brainstem Control of Neurotic and Psychotic Processes Jacques St.
Laurent, M.D.
42. Brain Stimulation: Why, Where, and How? Harold A. Sackeim, Ph.D.;
Collaborative Session With the National Institute of Mental Health
43. New Findings on Daily Prefrontal Repetitive Transcranial Magnetic
Stimulation for Depression Mark S. George, M.D.; Collaborative Session
With the National Institute of Mental Health
Session 15. Aspects of Bipolar Disorder
44. Negative Impact of Medical Comorbidity on the Course of Bipolar
Disorder Dan V. Iosifescu, M.D.; Collaborative Session With the National
Institute of Mental Health
45. Lithium Continuation/Discontinuation After Four Years of Stability
Eric D. Peselow, M.D.
46. Magnitude of the Effects of Quetiapine Treatment in Bipolar Disorder
Wayne Macfadden, M.D.
Session 16. Child and Adolescent Psychopharmacology
47. Pediatric Formulation of Modafinil Effective in Children and
Adolescents With ADHD James M. Swanson, M.D.
48. Modafinil Pediatric Formulation Has Early and Sustained Effect in ADHD
Joseph Biederman, M.D.
49. Polypharmacy Among Youths: How Prevalent Is It? Farifteh F.
Duffy
Session 17. PTSD and Anxiety
50. PTSD Depression and Anger in Patients Recovered From SARS Rima
Styra, M.D.
51. Are Anxiety Disorders Underdiagnosed and Undertreated in Psychiatry?
Joshua E. Wilk, Ph.D.
52. Biological Findings in PTSD: Can They Be Changed by Psychotherapy?
Friedhelm Lamprecht, M.D.
Session 18. Issues in Biological Psychiatry
53. The Family Genetic Study of Pathological Gambling Donald W. Black,
M.D.
54. Metabolic Syndrome in Psychiatric Inpatients Receiving Antipsychotics
John W. Goethe, M.D.
55. Anorexia Nervosa and Bulimia Nervosa: From Culture to Genes Pamela
K. Keel, Ph.D.; Collaborative Session With the National Institute of Mental
Health
Component Workshops
CW27. Benzodiazepines and Opiates in the Elderly: Use, Misuse, and
Abuse APA Committee on Access and Effectiveness of Psychiatric
Services for the Elderly; Chairperson: Allan A. Anderson, M.D.
CW28. Re-Engineering Clinical Research Training: The NPTC APA
Council on Research; Co-Chairpersons: John F. Greden, M.D., James F. Leckman,
M.D.
CW29. I Do, But I Can't: Mental Health Issues Around Gay Marriage
APA Committee on Gay, Lesbian, and Bisexual Issues; Chairperson: Serena
Yuan Volpp, M.D.
CW30. Quotes and Misquotes: Resident Physicians Working With the
Media APA Committee of Residents and Fellows and the APA Office of
Communications and Public Affairs; Co-Chairpersons: William C. Wood, M.D.,
Hillarie Turner
CW31. Practicing Rewarding Psychiatry in Jails and Prisons: A
Practicum APA Caucus of Psychiatrists Working in Correctional
Settings; Chairperson: Henry C. Weinstein, M.D.
CW32. The Voice of APA Past and Present: Considerations for an Oral
History Project APA Corresponding Committee on History and Library;
Chairperson: Avram H. Mack, M.D.
CW33. When It's Not All in Your Head: Health, Mental Illness, Ethnicity,
and Recovery APA Council on Social Issues and Public
Psychiatry; Co-Chairpersons: Robert P. Cabaj, M.D., Matthew O. Hurford,
M.D.
Issue Workshops
IW44. Topics in Psychosomatic Medicine: Fatigue in Cancer and AIDS
Co-Chairpersons: William Breitbart, M.D., Andrew J. Roth, M.D.;
Collaborative Session With the National Institute of Mental Health
IW45. How to Launch a Successful Private Practice (Part 2)
Co-Chairpersons: William E. Callahan Jr., M.D., Keith W. Young,
M.D.
IW46. Strategies for Success for Early Career Academic Psychiatrists
(Part 2): Promotion Chairperson: Laura W. Roberts, M.D.; Collaborative
Session With the National Institute of Mental Health
IW47. Responding to the Impact of Suicide on Clinicians
Chairperson: Eric M. Plakun, M.D.
IW48. Cannabis-Dependence Treatment: Where We Are, Where We Are
Going National Institute on Drug Abuse; Chairperson: Francis J. Vocci,
Ph.D.
IW49. Boundaries and Supervision: Avoiding Legal Risks and Doing Good
Clinical Work Chairperson: Werner Tschan, M.D.
IW50. Psychiatric Comorbidities in HIV Infection Chairperson:
David Stoff, Ph.D.; Collaborative Session With the National Institute of
Mental Health
IW51. Renewing Integrity Through Film: An Essential Virtue of
Professionalism Chairperson: Francis G. Lu, M.D.
IW52. The Long-Term Effects of Violence in Shaping Minority
Communities Co-Chairpersons: Napoleon B. Higgins Jr., M.D., Aruna S.
Rao, M.D.
IW53. The Movies and the Mind Chairperson: Willem C.
Tuinebreijer
IW54. American Indian Telepsychiatry: Bridging Culture and Distance
Chairperson: James H. Shore, M.D.
IW55. Chronic Fatigue Syndrome and Gulf War Illness: Pathology or
Abnormal Illness Behavior? Chairperson: Peter Manu, M.D.
IW56. Computer-Assisted CBT in Education and Treatment
Chairperson: Jesse H. Wright, M.D.
Noon-1:30 p.m.
Forums
4. Psychiatric Management of Treatment-Resistant Schizophrenia
Co-Chairpersons: John S. McIntyre, M.D., Darrel A. Regier, M.D.
5. How Psycho-Oncology Came to Be Chairperson: Philip R. Muskin,
M.D.
6. Identity as Psychiatrists: Heritage and Creativity in This Unique
Specialty Co-Chairpersons: Carlyle H. Chan, M.D., Charles Raison,
M.D.
Noon-2 p.m.
New Research Poster Session 6
1 p.m.-5 p.m.
CME Courses 73-79
2 p.m.-3:30 p.m.
Lectures
L14. Genes, Cognition, and Emotion Daniel R. Weinberger, M.D.,
Frontiers of Science Lecture Series; Collaborative Session With the National
Institute of Mental Health
L15. The Federal Regulation of Biomedical Research: A Study in Quid Pro
Quos Robert P. Charrow, Esq.
L16. Eating Disorders in Middle and Late Life: Diagnosis and Treatment
of a Neglected Problem Kathryn J. Zerbe, M.D., APA's Alexandra Symonds
Award Lecture
2 p.m.-5 p.m.
Presidential Symposia
3. Toward an Integrated Subspecialty of Psychosomatic Medicine
American Psychosomatic Society; Chairperson: Richard D. Lane,
M.D.
4. Mental Health and Sub-Saharan Africa: A 21st-Century Perspective
World Psychiatric Association; Co-Chairpersons: Michelle B. Riba, M.D.,
Ahmed M.F. Okasha, M.D.
Symposia
S27. Neuroscience for the Psychiatrist (Part 1): Neuroimaging From
Genomics to Therapy Collaborative Session With the National Institute
of Mental Health
A. Imaging Genomics in Psychiatry Andreas Meyer-Lindenberg,
M.D.
B. fMRI: Basics and Beyond Peter A. Bandettini, Ph.D.
C. Understanding Schizophrenia Using Functional Brain Imaging Cameron
Carter, M.D.
D. Linking Imaging and Treatment Mechanisms for Depression Helen S.
Mayberg, M.D.
S28. Real-Life Medical Management of HIV
A. HIV Treatment Update Khakasa H. Wapenyi, M.D.
B. Managing Mood Disorders Milton L. Wainberg, M.D.
C. Managing Hepatitis C, Syphilis, and HIV Infection Annette M.
Matthews, M.D.
D. Managing Psychosis Shahrad R. Amiri, M.D.
E. Managing Metabolic Syndromes Marshall Forstein, M.D.
S29. Psychosomatic Medicine: Integrating Epidemiology, Psychiatry, and
Medicine
A. Risk of Myocardial Infarction Associated With Panic Disorder Andres
Gomez-Caminero, Ph.D.
B. The Prevalence of Depressive Disorders in Patients With Dementia in
IHCIS Dimitri Bennett, M.D.
C. Diabetes and Lipid-Profile Risks With Neuroleptics: Two- to Five-Year
Outcome Robert C. Joseph, M.D.
D. Somatic Complaints in Traumatized Children Ruby C. Castilla-Puentes,
M.D.
E. A Case-Control Study of Erectile Dysfunction Among Men Diagnosed With
Panic Disorder William Blumentals, Ph.D.
S30. The Art and Science of Brief Therapies
A. Expectancy, the Ignored Common Factor: Creating Hope in Psychotherapy
Roger P. Greenberg, Ph.D.
B. Solution-Focused Brief Therapy: Doing What Works Brett Steenbarger,
Ph.D.
C. Brief Interpersonal Therapy Scott Stuart, M.D.
D. Cognitive Therapy: Practice and Training Judith S. Beck,
Ph.D.
S31. Posttraumatic Stress and Medical Illness: Interdisciplinary
Perspectives
A. PTSD in Medically Ill Adults and Children: A Review Eyal Shemesh,
M.D.
B. PTSD Symptoms in Children Who Had Transplants: One Center's Experience
Sukru Emre, M.D.
C. The Study of PTSD in the Medically Ill: Choice of Outcome Measures
Gad Cotter, M.D.
D. The National Child Traumatic Network Medical Trauma Toolkit Margaret
L. Stuber, M.D.
S32. Medical Comorbidity in the U.S. and France: Vive La Difference!
French Federation of Psychiatry
A. Mortality in a Cohort of Patients With Schizophrenia Frederic
Limosin, M.D.
B. Prevalence, Treatment, and Prevention of HIV/Hepatitis in the U.S.
Lisa B. Dixon, M.D.
C. Adverse Metabolic Effects of Antipsychotics in Schizophrenia Marie
France Poirier, M.D.
D. Diabetes and Other Metabolic Disorders in Schizophrenia Michael J.
Sernyak, M.D.
E. The Impact of Smoking in Patients With Schizophrenia Alain Dervaux,
M.D.
F. Medical Comorbidities and Health Behaviors: Smoking, Exercise, and
Weight Gail L. Daumit, M.D.
S33. Medical and Psychiatric Issues in the Mexican-American Population
in the U.S.
A. Health Status of Mexican Americans Michael P. Stern, M.D.
B. Depression as Comorbid Condition With Type-2 Diabetes in a U.S.-Mexico
Border Community Clinic Roberto Villarreal, M.D.
C. Insights on Schizophrenia in Three Countries Rolando A. Medina,
M.D.
S34. Atypical Antipsychotics: Treatment of Agitation Across Mental
Disorders
A. Treatment of Agitation With Atypical Antipsychotics in Schizophrenia
Stephen R. Marder, M.D.
B. Treatment of Agitation With Atypical Antipsychotics in Bipolar Affective
Disorder Gary S. Sachs, M.D.
C. Treatment of Agitation With Atypical Antipsychotics in Alzheimer's
Disease Jacobo E. Mintzer, M.D.
D. Assessing the Data in the Context of Clinical Care Eric D. Caine,
M.D.
S35. The Many Faces of Depression: Do Antidepressants Treat Different
Symptoms?
A. Do Antidepressants Treat Different Core Symptoms of Depression? J.
Craig Nelson, M.D.
B. Anger Attacks in Depression: Does 5HT Matter? Maurizio Fava,
Ph.D.
C. Positive and Negative Affect and Antidepressant Response Pedro L.
Delgado, M.D.
D. How Do Antidepressants Affect the Processing of Posistive and Negative
Emotional Information? Catherine J. Harmer, D.Phil.
E. The Role of Dopamine in Depression: Implications for Treatment
Anthony J. Rothschild, M.D.
S36. Understanding and Treating Alcohol Dependence
A. Neuropharmacological Basis of Alcohol Dependence George F. Koob,
Ph.D.
B. New Pharmacological Strategies for Treating Alcohol Dependence
Barbara J. Mason, Ph.D.
C. Recent Developments in the Genetics of Alcohol Dependence Marc A.
Schuckit, M.D.
D. New Medications: The Use of Anticonvulsants, Both Alone and in
Combination With Various Forms of Psychotherapy Bankole A. Johnson,
M.D.
E. Differential Effects of Pharmacological Agents on Craving Nassima
Ait-Daoud, M.D.
S37. Evidence-Based Psychiatry: What It Is and What It Is Not
A. Evidence-Based Medicine in Psychiatry: An Overview Gregory E. Gray,
M.D.
B. Evidence-Based Approaches to Teaching and Practicing Psychopharmacology
David N. Osser, M.D.
C. Uses and Abuses of EBM in Psychiatry S. Nassir Ghaemi, M.D.
D. Evidence-Based Medicine: How It Can Be Misused David T. Healy,
M.D.
E. EBM and Pharmaceutical Industry-Sponsored Clinical Trials Amir H.
Kalali, M.D.
S38. How to Launch a Successful Private Practice (Part 3)
A. Personal Factors Leading to a Successful Private Practice William E.
Callahan Jr., M.D.
B. Office Location and Design for Efficiency and Success Keith W.
Young, M.D.
C. Streamlining Overhead and Managing Your Business in Private Practice
Keith W. Young, M.D. D. Marketing Your Unique Private Practice
William E. Callahan Jr., M.D.
S39. Complex Pharmacotherapy Versus Polypharmacy
A. Polypharmacy and Ethnic Minorities William Lawson, M.D.
B. Impulsive Behavior in Children and Adolescents Janice G. Hutchinson,
M.D.
C. Polypharmacy in Depression and Anxiety: What, When, and How to Implement
Gabriela Cora-Locatelli, M.D.
D. Complexities of Bipolar Illness Typically Require Complex Combination
Therapy Robert M. Post, M.D.
E. Polypharmacy in Schizophrenia Treatment David C. Henderson,
M.D.
S40. Integrating and Sequencing Treatments for Borderline
Patients
A. Phases and Stages of Change in the Treatment of Personality Disorder
John Livesley, Ph.D.
B. Adapting Dialectical Behavior Therapy for the Psychiatric Practitioner
Barbara H. Stanley, Ph.D.
C. Common Mechanisms in Psychological Theories: Attachment and
Mentalization Peter Fonagy, Ph.D.
D. Toward a Rational Pharmacotherapy of BPD Larry J. Siever,
M.D.
E. Psychoeducation for Family Members With a Relative With BPD Perry D.
Hoffman, Ph.D.
S41. Maternal Depression and Comorbidities: Impact on Infants
A. Maternal Depression and Comorbidities: PTSD and BPD Marian I.
Butterfield, M.D.
B. Perinatal Depression: Impact of Maternal Distress on Neonatal Outcomes
and Attachment Sheila M. Marcus, M.D.
C. Impact of Maternal BPD on Infant Emotional Regulation Gisèle
Apter-Danon, Ph.D.
D. How Early Life Experience Affects the Development of Optimism's Neural
Circuitry Susan C. Vaughan, M.D.
S42. ADHD: From Neuroscience to Practice Collaborative Session
With the National Institute of Mental Health
A. Psychiatric and Functional Outcome of Adolescent Females With ADHD: A
Large, Controlled, Five-Year Longitudinal Follow-Up Study Joseph
Biederman, M.D.
B. Nonstimulant Treatment of Adult ADHD Thomas J. Spencer,
M.D.
C. Neuropsychology of ADHD: Clinical and Scientific Implications of Recent
Findings Alysa E. Doyle, Ph.D.
D. Heritability: New Genetic Findings in ADHD Pamela Sklar,
M.D.
E. Looking at the ADHD Brain: Neuroimaging Studies in ADHD Larry J.
Seidman, Ph.D.
S43. Associations Between Stress/Anxiety and Personality Styles and
Disorders Association for Research in Personality Disorders
A. A Selective Overview of Relationship of Anxiety and Personality
Disorders James H. Reich, M.D.
B. Schema Therapy for Maladaptive Personality Traits Involving Anxiety
David Bernstein
C. Personality and Stress in Three Phases of the Physician's Career: A
Longitudinal Nationwide Study Per Vaglum, M.D.
D. Panic, Rage, and Family Discord in BPD David M. Allen, M.D.
E. Is Emotional Dyscontrol and Impulsivity Related to Suicidal Ideation in
BPD Patients? Navjot Chaudhary, B.S.C.
F. Stress, Personality Disorders, and Opioid Receptors Kenneth Silk,
M.D.
S44. Perinatal Depression: Prevalence, Screening Accuracy, and
Intervention
A. A Systematic Review of the Evidence on the Incidence and Prevalence of
Perinatal Depression Norma I. Gavin, Ph.D.
B. What Is the Accuracy of Different Screening Tools for Detecting
Depression During the Perinatal Period? Bradley N. Gaynes, M.D.
C. Does Perinatal Screening for Depressive Symptoms With Subsequent
Intervention Lead to Improved Outcomes? A Systematic Review of the Evidence
Samantha E. Meltzer-Brody, M.D.
S45. The Long-Term Psychological Aftermath of 9/11-Related Traumatic
Loss
A. Traumatic Grief Among 9/11 Victims Yuval Y. Neria, Ph.D.
B. Trauma, Bereavement, and Traumatic Loss George A. Bonanno,
Ph.D.
C. A Nationwide Longitudinal Study of Responses to the 9/11 Terrorist
Attacks Roxane C. Silver, Ph.D.
D. Loss and Consequences After Mass Trauma: Examples From the 9/11
Terrorist Attacks in New York City Sandro Galea, M.D.
E. 9/11-Related Traumatic Loss and Its Psychopathology in Primary Care
Patients in New York City Raz Gross, M.D.
S46. Rehabilitation of the Mad or Bad: Globally American
Association for Psychosocial Rehabilitation and the World Psychiatric
Association's Section on Rehabilitation
A. Mad or Bad? Japan Naotaka Shinfuku, M.D.
B. Mad or Bad? United States Zebulon Taintor, M.D.
C. Mad or Bad? Hungary Ida Kosza, M.D.
D. Mad or Bad? Pakistan Afzal Javed, M.D.
E. Mad or Bad? International Efforts Humberto Martinez, M.D.
S47. New Developments in the Treatment of Somatoform Disorders
A. Pharmacotherapy of Somatoform Disorders Brian A. Fallon,
M.D.
B. Managing Common Somatic Presentations in Primary Care: Cultural
Considerations Javier I. Escobar, M.D.
C. Cognitive-Behavior Therapy for Hypochondriasis: A Randomized, Controlled
Intervention Trial Arthur J. Barsky, M.D.
D. Treatment of Unexplained Somatic Symptoms in Children and Adolescents
Joshua D. Lipsitz, Ph.D.
E. Integrative Treatment for Fibromyalgia/Chronic Fatigue Syndrome
Richard P. Brown, M.D.
S48. Inpatient Psychiatry: Crisis and Response
A. Public Policy and Inpatient Psychiatric Care Anita S. Everett,
M.D.
B. An Updated Model for Inpatient Psychiatric Care Ira D. Glick,
M.D.
C. Crisis Residential Care for Patients With Serious Mental Illness:
Outcomes and Cost Wayne S. Fenton, M.D.
D. A National Referral Center for Treatment-Resistant Patients Edward
R. Shapiro, M.D.
E. Trends and Characteristics of Inpatient Treatment in Routine Psychiatric
Practice in the U.S. Joshua E. Wilk, Ph.D.
S49. Advances and Innovations in Assessing Decision-Making
Capacity
A. Evaluating Decisional Capacity in Older Patients Barton W. Palmer,
Ph.D.
B. Error Behaviors in Capacity Interviews Scott Y. Kim, M.D.
C. Distinguishing Research From Clinical Care Laura B. Dunn,
M.D.
D. Capacity for Informed Consent in Patients With Schizophrenia David
J. Moser, Ph.D.
S50. Novel Research Treatments for Eating Disorders
Collaborative Session With the National Institute of Mental
Health
A. Atypical Antipsychotic Medication for Anorexia Nervosa Evelyn Attia,
M.D.
B. New Medication Treatments for Binge-Eating Disorder Jose C.
Appolinario, M.D.
C. CD-ROM-Based Treatment for Binge-Eating Disorder and Obesity Cynthia
M. Bulik, Ph.D.
D. How the Study of Mechanism May Inform Treatment of Bulimia Nervosa
B. Timothy Walsh, M.D.
E. D-Cycloserine and Anorexia Nervosa: Clinical Implications of
Translational Research Joanna E. Steinglass, M.D.
S51. Neuroscience and Dynamic Psychiatry American Academy of
Psychoanalysis and Dynamic Psychiatry
A. Psychotherapy and Neurobiology Richard M. Brockman, M.D.
B. Contemporary Affect Theory and Controversies Regarding Drive Theory in
Psychoanalysis Otto F. Kernberg, M.D.
C. Imaging the Mind-Brain Interface Bridging the
Psychoanalysis-Neuroscience Gap David A. Silbersweig, M.D.
D. How Neuroscience Can Help the Clinician Samuel Slipp, M.D.
S52. Disturbed Fronto-Limbic Brain Circuitry: How Specific Is It for
Different Psychiatric Disorders?
A. Fronto-Limbic Brain Pathology: Evidence From Animal Research Gregory
Quirk, Ph.D.
B. Fronto-Limbic Brain Pathology in PTSD Eric Vermetten, M.D.
C. Prefrontal and Limbic Pathology in BPD Klaus Lieb, M.D.
D. Stress-Induced Brain Structural Plasticity: What Do Animal Models Tell
Us? Bruce S. McEwen, Ph.D.
E. Neural Circuits in Trauma Spectrum Disorders J. Douglas Bremner,
M.D.
S53. Increases in Opioid Analgesic Abuse: Concerns and Strategies
National Institute on Drug Abuse
A. Increases in Opioid Analgesic Use, Misuse, and Addiction Wilson M.
Compton III, M.D.
B. The Availability of Opioid Medications Over the Internet Without a
Prescription Robert F. Forman, Ph.D.
C. Managing Chronic Pain in the Patient With Comorbid Substance Abuse
Nathaniel P. Katz, M.D.
D. Treatment of Prescription Analgesic Abuse Herbert D. Kleber,
M.D.
S54. Psychiatry and the Pharmaceutical Industry: Where Is the
Boundary?
A. Pharmaceutical Promotions: Effects on the Practice of Psychiatry Amy
C. Brodkey, M.D.
B. Academic Medicine, Medical Education, and the Pharmaceutical Industry
Frederick S. Sierles, M.D.
C. The Pharmaceutical Industry, Psychiatry, and the Public Interest
Robert M. Factor, M.D.
D. Dancing With Porcupines: Dilemmas Faced by Speakers for the
Pharmaceutical Industry Diana M. Koziupa, M.D.
S55. Autism: A Common, Severe, Treatable, and Neglected Psychiatric
Illness Collaborative Session With the National Institute of Mental
Health
A. A Comprehensive Review of Major Research Findings in Autism From the
Past Decade Eric B. London, M.D.
B. Biology of Social Behavior From Mice to Monkeys James T. Winslow,
Ph.D.
C. fMRI Studies of Social Perception and Social Cognition in Autistic
Disorder Robert T. Schultz, Ph.D.
D. Targeted Treatments for the Repetitive Behavior Domain in Autism
Eric Hollander, M.D.
E. Atypical Antipsychotics in Children With Pervasive Developmental
Disorders Lawrence Scahill, Ph.D.
2 p.m.-5:30 p.m.
Review of Psychiatry (Section 1): Sleep Disorders and Psychiatry
Chairperson: Daniel J. Buysse, M.D.
1. Insomnia Daniel J. Buysse, M.D.
2. Sleep-Related Breathing Disorders Patrick J. Strollo, M.D.
3. Restless Leg Syndrome and Parasomnias John W. Winkelman,
M.D.
4. Circadian Rhythm Sleep Disorders Phyllis C. Zee, M.D.
3 p.m.-5 p.m.
New Research Poster Session 7
6 p.m.-8 p.m.
Special Session
Global Disasters: Psychiatric Medicine and Public Health Challenges
APA Council on Global Psychiatry and World Psychiatric Association
Conflict Management and Conflict Resolution Section, Co-Chairpersons: Rodrigo
A. Muñoz, M.D., Eliot Sorel, M.D.; Presenters: Srinivan Murthy, M.D.,
M. Paramsheva Deva, M.D., Lennart Levi, M.D.; Discussants: Professor Mordechai
Benyakar, Anthony T. Ng, M.D.
7 p.m.-10 p.m.
Industry-Supported Symposia
IS39. Seasonal Affective Disorder: New Concepts, Practical
Strategies Supported by GlaxoSmithKline
A. The Clinical Picture and Epidemiology of SAD Norman E. Rosenthal,
M.D.
B. Pathophysiology of Seasonal Affective Disorder Thomas A. Wehr,
M.D.
C. Light Treatment for Winter Depression: Status Report Raymond W. Lam,
M.D.
D. Medical Treatment Including Mechanism of Action: New Study Data
Jennifer K. Pennell, M.D.
E. Integrating Cognitive-Behavioral Therapy Into Seasonal Affective
Disorder Treatment Kelly J. Rohan, Ph.D.
IS40. Alcoholism: Translating Emerging Science Into Clinical
Practice Supported by Alkermes
A. Animal Models Point the Way to Novel Therapies George F. Koob,
Ph.D.
B. Brain Imaging of Craving and the Effects of Anticraving Medications
Charles P. O'Brien, M.D.
C. Advances in the Pharmacotherapy of Alcoholism Helen M. Pettinati,
Ph.D.
D. Alcoholism and Other Psychiatric Disorders: How Do We Manage Dual
Diagnosis? Hugh Myrick, M.D.
IS41. Advances in Cholinergic Therapy: Alzheimer's Disease and
Beyond Supported by Eisai Inc.
A. Revisiting the Cholinergic Hypothesis: Are Cholinesterase Inhibitors
More Than Symptomatic Treatments for Alzheimer's Disease? Norman Relkin,
M.D.
B. The Role of Imaging in the Study and Treatment of Dementia K. Ranga
R. Krishnan, M.D.
C. Clinical Trials in Cognitive Impairment Ronald C. Petersen,
M.D.
D. Pharmacological Treatment of Cognitive Impairments in Schizophrenia
Robert W. Buchanan, M.D.
E. Behavioral Disturbances in Alzheimer's Disease: Diagnosis and Management
Helen Lavretsky, M.D.
IS42. Challenges at the Interface of Psychiatric, Medical, and Sleep
Disorders Supported by Sanofi-Synthelabo Inc.
A. Epidemiological and Longitude Perspectives on Insomnia and Psychiatric
Illness Daniel E. Ford, M.D.
B. Changing Women's Sleep Vulnerabilities Across the Life Cycle Lois
Krahn, M.D.
C. Sleep Disturbances and Neurodegenerative Disorders Raymond R. Auger,
M.D.
D. Metabolic Consequences of Insomnia: Implications for Medicine and
Psychiatry Gary S. Richardson, M.D.
E. Therapeutic Challenges in Treating Insomnia With Comorbid Psychiatric
and Medical Disorders David N. Neubauer, M.D.
IS43. It's Not Just for Kids: ADHD in Adolescence and Adulthood
Supported by Shire US Inc.
A. The Course of ADHD From Adolescence Into Adulthood Christopher J.
Kratochvil, M.D.
B. Neurobiological Update on ADHD in Adolescence and Adulthood Stephen
V. Faraone, Ph.D.
C. New Psychotherapies Directed at Young Adults With ADHD Steven A.
Safren, Ph.D.
D. College Considerations in Young Adults With ADHD Sharon B. Wigal,
Ph.D.
E. Medication Considerations in Young Adults With ADHD Timothy Wilens,
M.D. 
Get information about faster international access.
Privacy Policy
Copyright © 2005
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
| 
